Search

everythinglearnresearchcommunity

for

Search:↓

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

Mutations in the AR gene cause hair thinning and loss.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

A 13-year-old girl's masculine symptoms improved after surgery for a rare adrenal tumor that produced male hormones.

Androgenetic alopecia may predict metabolic syndrome, so routine screening is recommended to prevent cardiovascular issues.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Minoxidil can reduce functions related to androgen receptors.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

New imaging techniques show testosterone delays hair growth and shrinks follicles in mice, but have limited depth for viewing.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Combining triamcinolone microinjections with minoxidil improves hair growth in women more than minoxidil alone.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Inflammation damages sweat ducts, causing sweat gland injury.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Androgen receptor differences may contribute to hair loss in AGA patients.

Androgen receptor expression is similar in affected and unaffected scalp areas in androgenetic alopecia.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The woman had a rare adrenal tumor removed, and she recovered well with no signs of the tumor returning.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

5ARI treatment improves hair growth in older men with minimal side effects.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.